USITC to investigate Daewoong following Allergan complaint

The US International Trade Commission (ITC) has begun an investigation into Daewoong Pharmaceuticals of South Korea and California-based Evolus, following a complaint from Allergan.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

US ITC bars imports of low-cost Botox amid trade secrets dispute

18 December 2020 The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.

Big Pharma

Allergan says rivals using trade secrets disclosed by USITC order

13 August 2019 Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.

Medtech

USITC to investigate blood separation devices

8 March 2019 The US International Trade Commission has instituted an investigation into certain blood separation and cell preparation devices.